Revance Therapeutics Gross Profit (Quarterly) Analysis

Revance Therapeutics Inc (RVNC)

3.15 -0.16 (-4.83%) USD | NASDAQ | May 16, 16:00

3.16 +0.01 (+0.32%) After-Hours: 20:00

Gross Profit (Quarterly) Chart

Historical Gross Profit (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	37.02M
December 31, 2023	52.33M
September 30, 2023	37.36M
June 30, 2023	36.83M
March 31, 2023	33.29M
December 31, 2022	26.41M
September 30, 2022	18.28M
June 30, 2022	18.84M
March 31, 2022	17.37M
December 31, 2021	18.07M
September 30, 2021	13.86M
June 30, 2021	13.38M
March 31, 2021	9.082M
December 31, 2020	7.47M
September 30, 2020	2.75M
June 30, 2020	0.278M
March 31, 2020	0.058M
December 31, 2019	0.089M
September 30, 2019	0.046M
June 30, 2019	0.00
March 31, 2019
December 31, 2018
September 30, 2018

Date	Value
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013	0.075M

Gross Profit Definition

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (Quarterly) Range, Past 5 Years

Minimum

Jun 2019

52.33M

Maximum

Dec 2023

17.14M

Average

15.61M

Median

Gross Profit (Quarterly) Benchmarks